BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24033080)

  • 1. Vaccine-associated enhanced respiratory disease does not interfere with the adaptive immune response following challenge with pandemic A/H1N1 2009.
    Gauger PC; Loving CL; Lager KM; Janke BH; Kehrli ME; Roth JA; Vincent AL
    Viral Immunol; 2013 Oct; 26(5):314-21. PubMed ID: 24033080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of lung lesion development and pro-inflammatory cytokine response in pigs with vaccine-associated enhanced respiratory disease induced by challenge with pandemic (2009) A/H1N1 influenza virus.
    Gauger PC; Vincent AL; Loving CL; Henningson JN; Lager KM; Janke BH; Kehrli ME; Roth JA
    Vet Pathol; 2012 Nov; 49(6):900-12. PubMed ID: 22461226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (δ-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus.
    Gauger PC; Vincent AL; Loving CL; Lager KM; Janke BH; Kehrli ME; Roth JA
    Vaccine; 2011 Mar; 29(15):2712-9. PubMed ID: 21310191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live attenuated influenza A virus vaccine protects against A(H1N1)pdm09 heterologous challenge without vaccine associated enhanced respiratory disease.
    Gauger PC; Loving CL; Khurana S; Lorusso A; Perez DR; Kehrli ME; Roth JA; Golding H; Vincent AL
    Virology; 2014 Dec; 471-473():93-104. PubMed ID: 25461535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza A virus hemagglutinin protein subunit vaccine elicits vaccine-associated enhanced respiratory disease in pigs.
    Rajão DS; Loving CL; Gauger PC; Kitikoon P; Vincent AL
    Vaccine; 2014 Sep; 32(40):5170-6. PubMed ID: 25077416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine-associated enhanced respiratory disease is influenced by haemagglutinin and neuraminidase in whole inactivated influenza virus vaccines.
    Rajão DS; Chen H; Perez DR; Sandbulte MR; Gauger PC; Loving CL; Shanks GD; Vincent A
    J Gen Virol; 2016 Jul; 97(7):1489-1499. PubMed ID: 27031847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs.
    Souza CK; Rajão DS; Loving CL; Gauger PC; Pérez DR; Vincent AL
    Clin Vaccine Immunol; 2016 Jun; 23(6):470-482. PubMed ID: 27030585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.
    Khurana S; Loving CL; Manischewitz J; King LR; Gauger PC; Henningson J; Vincent AL; Golding H
    Sci Transl Med; 2013 Aug; 5(200):200ra114. PubMed ID: 23986398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous challenge in the presence of maternally-derived antibodies results in vaccine-associated enhanced respiratory disease in weaned piglets.
    Rajao DS; Sandbulte MR; Gauger PC; Kitikoon P; Platt R; Roth JA; Perez DR; Loving CL; Vincent AL
    Virology; 2016 Apr; 491():79-88. PubMed ID: 26874588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of humoral and cellular immune responses to inactivated swine influenza virus vaccine in weaned pigs.
    Platt R; Vincent AL; Gauger PC; Loving CL; Zanella EL; Lager KM; Kehrli ME; Kimura K; Roth JA
    Vet Immunol Immunopathol; 2011 Aug; 142(3-4):252-7. PubMed ID: 21664701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
    Kitikoon P; Nilubol D; Erickson BJ; Janke BH; Hoover TC; Sornsen SA; Thacker EL
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):117-28. PubMed ID: 16621020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
    Thomas M; Wang Z; Sreenivasan CC; Hause BM; Gourapura J Renukaradhya ; Li F; Francis DH; Kaushik RS; Khatri M
    Vaccine; 2015 Jan; 33(4):542-8. PubMed ID: 25437101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
    Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
    J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy of an inactivated Eurasian avian-like H1N1 swine influenza vaccine against homologous H1N1 and heterologous H1N1 and H1N2 viruses in mice.
    Sui J; Yang D; Qiao C; Xu H; Xu B; Wu Y; Yang H; Chen Y; Chen H
    Vaccine; 2016 Jul; 34(33):3757-63. PubMed ID: 27321744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of pigs against pandemic swine origin H1N1 influenza A virus infection by hemagglutinin- or neuraminidase-expressing attenuated pseudorabies virus recombinants.
    Klingbeil K; Lange E; Blohm U; Teifke JP; Mettenleiter TC; Fuchs W
    Virus Res; 2015 Mar; 199():20-30. PubMed ID: 25599604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polyvalent influenza A DNA vaccine induces heterologous immunity and protects pigs against pandemic A(H1N1)pdm09 virus infection.
    Bragstad K; Vinner L; Hansen MS; Nielsen J; Fomsgaard A
    Vaccine; 2013 Apr; 31(18):2281-8. PubMed ID: 23499598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses.
    Xu J; Yang D; Huang D; Xu J; Liu S; Lin H; Zhu H; Liu B; Lu C
    Arch Virol; 2013 Mar; 158(3):629-37. PubMed ID: 23135159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs.
    Reeth KV; Brown I; Essen S; Pensaert M
    Virus Res; 2004 Jul; 103(1-2):115-24. PubMed ID: 15163499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-fostering to prevent maternal cell transfer did not prevent vaccine-associated enhanced respiratory disease that occurred following heterologous influenza challenge of pigs vaccinated in the presence of maternal immunity.
    Loving CL; Brockmeier SL; Vincent AL; Gauger PC; Zanella EL; Lager KM; Kehrli ME
    Viral Immunol; 2014 Sep; 27(7):334-42. PubMed ID: 24978861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs.
    Wen F; Yu H; Yang FR; Huang M; Yang S; Zhou YJ; Li ZJ; Tong GZ
    Arch Virol; 2014 Nov; 159(11):2957-67. PubMed ID: 24957653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.